Mississippi Center for Clinical and Translational Research

密西西比临床和转化研究中心

基本信息

  • 批准号:
    10281515
  • 负责人:
  • 金额:
    $ 210.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-18 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY. Mississippi has some of the nation's worst health outcomes and was ranked by the United Health Foundation as the “least healthy state” in 2019. Further, the racial disparities surrounding these health outcomes are profound. The complexities associated with effectively addressing Mississippians' health outcomes and ameliorating Mississippi's health disparities necessitate a strong, multi-disciplinary research and outreach infrastructure. The Mississippi Center for Clinical and Translational Research (MCCTR) was established in 2016 to provide this infrastructure, equipping researchers with the resources needed to conduct clinical, translational, and population-based research projects. The MCCTR proposes to continue and expand its efforts through what it has termed as “Phase II.” In Phase II, the MCCTR will add two new institutional partners, Mississippi State University and University of Mississippi-Oxford, to its Phase I partners, University of Mississippi Medical Center, Tougaloo College, and University of Southern Mississippi. It will also add two CTR/CTSAs as collaborating partners, the University of Alabama at Birmingham's Center for Clinical and Translational Science and the Northwestern University Clinical and Translational Sciences, to its Phase I partners: Mayo Clinic's Center for Clinical and Translational Science and the Louisiana Clinical and Translational Science Center. The Administrative Core will be responsible for managing the administrative, fiscal, and scientific aspects of the MCCTR, including the oversight, marketing, and coordination of all MCCTR cores and activities. The Professional Development Core will offer structured mentorship, training opportunities, and protected research time for early stage investigators at MCCTR partner institutions. The Community Engagement and Outreach Core will provide training and support to investigators in conducting community engaged research; partner with healthcare providers through its new Practice-Based Research Network; and work with its expanded Community Advisory Board to provide bi-directional communication and guidance on community values, concerns, and needs and represent the MCCTR to Mississippi Communities. The Biostatistics, Epidemiology, and Research Design Core will provide training and assistance with research design, data collection and management, and statistical analysis to increase the effectiveness, efficiency, and success of research conducted by MCCTR investigators. The Pilot Projects Program will support clinical, translational, and population-based research projects likely to have a meaningful impact on Mississippi health outcomes and lead to extramural funding. The Research Services Core will support research projects through study coordination and regulatory support and will help connect researchers to communities through expanded telehealth and cohort-study resources. Finally, the Tracking and Evaluation Core will provide accurate and timely information on MCCTR performance and impact to inform planning and implementation by leadership and advisory bodies. Through the infrastructure of resources and personnel developed by MCCTR, Mississippi's health outcomes will be positively impacted.
项目摘要。密西西比州的健康状况是全国最差的, 联合健康基金会在2019年被评为“最不健康的州”。此外,围绕这些问题的种族差异 健康成果意义深远。有效解决密西西比人健康问题的复杂性 结果和改善密西西比的健康差距需要一个强大的,多学科的研究, 外联基础设施。密西西比临床和转化研究中心(MCCTR) 成立于2016年,旨在提供这一基础设施,为研究人员提供开展研究所需的资源。 临床、转化和基于人口的研究项目。MCCTR建议继续并扩大 它通过所谓的“第二阶段”来努力。在第二阶段,MCCTR将增加两个新的机构合作伙伴, 密西西比州立大学和密西西比-牛津大学,其第一阶段的合作伙伴,密西西比大学 医学中心、图加洛学院和南密西西比大学。它还将增加两个CTR/CTSA, 合作伙伴,位于伯明翰的亚拉巴马大学临床和转化科学中心 和西北大学临床和转化科学,其第一阶段的合作伙伴:马约诊所的中心 路易斯安那州临床和转化科学中心(Louisiana Clinical and Translational Science Center) 行政核心将负责管理行政、财政和科学方面的工作, MCCTR,包括所有MCCTR核心和活动的监督、营销和协调。的 专业发展核心将提供结构化的指导,培训机会和受保护的研究 为MCCTR合作机构的早期研究者提供时间。社区参与和推广 核心将为研究人员提供培训和支持,以开展社区参与的研究;与 通过其新的基于实践的研究网络的医疗保健提供者;并与其扩大的社区合作 咨询委员会就社区价值观、关注的问题和 需要和代表MCCTR到密西西比社区。生物统计学、流行病学和研究 设计核心将提供研究设计、数据收集和管理方面的培训和援助, 统计分析,以提高MCCTR进行的研究的有效性,效率和成功 investigators.试点项目计划将支持临床、转化和基于人群的研究 项目可能对密西西比健康结果产生有意义的影响,并导致校外资金。的 研究服务核心将通过研究协调和监管支持支持研究项目, 将通过扩大远程保健和队列研究资源帮助研究人员与社区联系。最后, 跟踪与评估核心将提供有关军事指挥控制与技术研究中心性能的准确和及时的信息, 领导和咨询机构为规划和执行工作提供信息。通过基础设施, 资源和人员开发的MCCTR,密西西比的健康成果将产生积极的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joey P. Granger其他文献

Intrauterine endotoxin infusion in rat pregnancy induces preterm delivery and increases placental prostaglandin F2alpha metabolite levels.
大鼠妊娠宫内输注内毒素可诱导早产并增加胎盘前列腺素 F2α 代谢水平。
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    William A. Bennett;D. Terrone;B. K. Rinehart;Sallah Kassab;James N. Martin;Joey P. Granger
  • 通讯作者:
    Joey P. Granger
[18-OR]: Enhanced angiogenic balance and vasorelaxation during pregnancy in obese MC4R-deficient rats
  • DOI:
    10.1016/j.preghy.2014.10.022
  • 发表时间:
    2015-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Frank T. Spradley;Ana C. Palei;Joey P. Granger
  • 通讯作者:
    Joey P. Granger
A new genetic clue to unravel the origins of pre-eclampsia
解开子痫前期起源的新遗传线索
  • DOI:
    10.1038/nrneph.2017.116
  • 发表时间:
    2017-09-04
  • 期刊:
  • 影响因子:
    39.800
  • 作者:
    Eric M. George;Joey P. Granger
  • 通讯作者:
    Joey P. Granger
[13-OR]: Role of nitric oxide on blood pressure regulation in pregnant rats on a high-fat diet (HFD)
  • DOI:
    10.1016/j.preghy.2014.10.017
  • 发表时间:
    2015-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ana C. Palei;Frank T. Spradley;Joey P. Granger
  • 通讯作者:
    Joey P. Granger
[279-POS]: Potential therapeutic value of the heme oxygenase system in preeclampsia
  • DOI:
    10.1016/j.preghy.2014.10.285
  • 发表时间:
    2015-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Eric M. George;Joey P. Granger
  • 通讯作者:
    Joey P. Granger

Joey P. Granger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joey P. Granger', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10281516
  • 财政年份:
    2016
  • 资助金额:
    $ 210.66万
  • 项目类别:
Mississippi Center for Clinical and Translational Research
密西西比临床和转化研究中心
  • 批准号:
    10472628
  • 财政年份:
    2016
  • 资助金额:
    $ 210.66万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10472630
  • 财政年份:
    2016
  • 资助金额:
    $ 210.66万
  • 项目类别:
MCCTR/UMMC Year4 N3C Grant Initiative
MCCTR/UMMC Year4 N3C 资助计划
  • 批准号:
    10887860
  • 财政年份:
    2016
  • 资助金额:
    $ 210.66万
  • 项目类别:
International Society for the Study of Hypertension in Pregnancy (ISSHP) World Congress
国际妊娠期高血压研究学会 (ISSHP) 世界大会
  • 批准号:
    8838489
  • 财政年份:
    2014
  • 资助金额:
    $ 210.66万
  • 项目类别:
Preeclampsia, IUGR and Hypertension: Targets for Treatment
先兆子痫、IUGR 和高血压:治疗目标
  • 批准号:
    8518448
  • 财政年份:
    2012
  • 资助金额:
    $ 210.66万
  • 项目类别:
Preeclampsia, IUGR and Hypertension: Targets for Treatment
先兆子痫、IUGR 和高血压:治疗目标
  • 批准号:
    8385761
  • 财政年份:
    2012
  • 资助金额:
    $ 210.66万
  • 项目类别:
Hypertension, Kidney and Pregnancy
高血压、肾脏和怀孕
  • 批准号:
    8247752
  • 财政年份:
    2011
  • 资助金额:
    $ 210.66万
  • 项目类别:
Hypertension, Kidney and Pregnancy
高血压、肾脏和怀孕
  • 批准号:
    8601899
  • 财政年份:
    2011
  • 资助金额:
    $ 210.66万
  • 项目类别:
Hypertension, Kidney and Pregnancy
高血压、肾脏和怀孕
  • 批准号:
    8433334
  • 财政年份:
    2011
  • 资助金额:
    $ 210.66万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 210.66万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了